Not CRISPR data: the image illustrates antibody quality for visualizing CRISPR experiment results.
Not CRISPR data: the image illustrates antibody quality for visualizing CRISPR experiment results.
CYP1A2 Double Nickase Plasmid (h): sc-401178-NIC
- Target species: human
- 20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
- CYP1A2 Double Nickase Plasmid (h) consists of a pair of plasmids each encoding a D10A mutated Cas9 nuclease and a target-specific 20 nt guide RNA (gRNA) designed to knockout gene expression with greater specificity than its CRISPR/Cas9 KO counterpart
- Paired gRNA sequences are offset by approximately 20 bp to allow for specific Cas9-mediated double nicking of the genomic DNA, which mimics a DSB
- One plasmid in the pair contains a puromycin-resistance gene for selection; the other plasmid in the pair contains a GFP marker to visually confirm transfection
- CYP1A2 Double Nickase Plasmid (h) and CYP1A2 Double Nickase Plasmid (h2) encode distinct paired gRNA designs targeting CYP1A2. One or both designs may be available
- Following transfection, gene knockout efficiency can be assayed by WB, IF or IHC using antibody: CYP1A2 Antibody (3B8C1): sc-53614
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
CYP1A2 Double Nickase Plasmid (h) | sc-401178-NIC | 20 µg | $410.00 | |||
CYP1A2 Double Nickase Plasmid (h2) | sc-401178-NIC-2 | 20 µg | $410.00 |
CYP1A2 encodes a hepatic cytochrome P450 monooxygenase that catalyzes oxidative metabolism of endogenous compounds and many xenobiotics, including caffeine and other aromatic substrates. As part of Phase I drug metabolism, CYP1A2 activity shapes bioactivation and clearance pathways by generating more polar metabolites and reactive intermediates that can influence oxidative stress and cellular redox homeostasis. Its expression is regulated by xenobiotic-sensing transcriptional programs, particularly aryl hydrocarbon receptor (AHR) signaling, linking environmental exposures to metabolic reprogramming. Interindividual variation in CYP1A2 function and regulation is widely studied for its impact on pharmacokinetic phenotypes, chemical susceptibility, and metabolism-associated liver biology.
CYP1A2 Double Nickase Plasmid (h) consists of a matched pair of plasmids engineered for high-specificity editing of the CYP1A2 locus in human cell lines. Each plasmid expresses a Cas9 D10A nickase and a distinct sgRNA targeting opposite DNA strands within CYP1A2. When directed to adjacent sites on opposite DNA strands, the two nickases generate offset single-strand nicks that together produce a staggered double-strand break, requiring coordinated on-target activity from both guides. The resulting DNA break is resolved by endogenous cellular repair pathways, most commonly through non-homologous end joining (NHEJ), leading to insertions or deletions that disrupt CYP1A2 function. By requiring dual sgRNA engagement at the target locus, the double nicking approach enhances editing specificity and provides a complementary CRISPR strategy for applications where additional control over targeting precision is desired.
To support efficient identification of edited cells, one plasmid encodes GFP for fluorescent visualization of transfected populations, while the companion plasmid carries a puromycin resistance gene for antibiotic selection. Together, these features support efficient enrichment of co-transfected populations and simplify the validation of CYP1A2-disrupted clones.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.